Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Pyrroloquinoline quinone (PQQ)

Pyrroloquinoline Quinone (PQQ / BioPQQ) · also known as Pyrroloquinoline quinone disodium salt, BioPQQ, PQQ

In cell and mouse experiments, PQQ can activate CREB and PGC-1α and raise mitochondria-related markers. After standard oral doses, serum levels are only in the nanomolar range. In humans, neither mitochondrial biogenesis nor direct free radical scavenging has been confirmed.

Typical dose: 10–20 mg/day, taken in the morning with water or a light meal.
Absorption and forms: Purified PQQ comes as the disodium salt and dissolves well in water. That does not show that fermentation-derived forms such as BioPQQ have a more stable conformation. After an oral dose of about 0.2 mg/kg, peak serum concentration in humans is roughly in the nanomolar range (an FDA data summary reports about 9 nM). That is not enough to show that such a small oral amount has a meaningful effect on human mitochondria.

Clinical uses and human evidence

Memory

BeneficialGrade B · Moderate evidence
Studies (2)
  1. Shiojima 2022 · J Am Nutr Assoc · RCT · n=64 — Effect of Dietary Pyrroloquinoline Quinone Disodium Salt on Cognitive Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
  2. Tamakoshi 2023 · Food Funct · RCT · n=70 — Pyrroloquinoline quinone disodium salt improves brain function in both younger and older adults

Attention and focus

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Shiojima 2022 · J Am Nutr Assoc · RCT · n=64 — Effect of Dietary Pyrroloquinoline Quinone Disodium Salt on Cognitive Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

Mechanisms of action

PGC-1α-driven mitochondrial biogenesis and proliferation

★★★☆☆Mechanism evidence: grade CSecondary target

PQQ can promote CREB phosphorylation and upregulate PGC-1α and TFAM, driving mitochondrial biogenesis. However, the concentrations in cell experiments (10–30 μM) and the intraperitoneal dosing in mice both deliver far more than typical oral use. There is no direct evidence that human tissue shows the same effect.

References (3)
  1. Chowanadisai 2010 · Cell experiment: 10–30 μM PQQ activated CREB/PGC-1α and increased mitochondria-related markers
  2. Cheng 2021 · Intraperitoneal injection in mice: PQQ changed PGC-1α, TFAM and mitochondrial markers
  3. Harris 2013 · Human pharmacokinetic study: after about 0.2 mg/kg orally, peak serum concentration was roughly in the nanomolar range, and an FDA data summary reports about 9 nM

Direct free radical trapping and chemical quenching

★☆☆☆☆Mechanism evidence: grade DSecondary target

PQQ has redox-cycling ability, but this property has been observed mainly in cell-free systems in vitro. Serum PQQ in humans is only at nanomolar levels, and redox cycling may also cause protein oxidation. It therefore cannot be concluded from this evidence that PQQ strongly scavenges free radicals in the body.

References (2)
  1. Hamagishi 1990 · In-vitro study: PQQ inhibited chemiluminescence and lipid peroxidation in brain tissue homogenates
  2. Akagawa 2010 · Cell-free experiment: PQQ redox cycling can also cause protein oxidation

Neurotrophic factor synthesis and TrkB/A receptor activation

★☆☆☆☆Mechanism evidence: grade DSecondary target

In cultured astrocytes, PQQ can promote the synthesis or secretion of NGF. The study that found increased NGF in the rat brain used a PQQ derivative, so it cannot be applied directly to oral PQQ. There is no evidence yet of the same change in the human brain.

References (2)
  1. Murase 1993 · Mouse astrocyte experiment: PQQ promoted NGF synthesis or secretion in cultured cells
  2. Yamaguchi 1993 · In-vitro and rat study: the rise in rat brain NGF was produced with a PQQ derivative and cannot be equated with oral PQQ

Safety and drug interactions

Long-term safety still needs study. Very high doses (above 40 mg) may cause a brief feeling of overstimulation, but there is no reliable evidence for a dose threshold, so it is not certain that 40 mg is the cutoff.
Open in the interactive app ›